Osaic Holdings’s Lipocine LPCN Stock Holding History
Bought
Maintained
Sold
Other funds holding LPCN
IC
SCM
EP
RA
VCM
ACM
SC
BFM
SFCM
BC
Osaic Holdings's LPCN Position: Q1 2026 in Review
Osaic Holdings increased its Lipocine (LPCN) stake by 21% in Q1 2026, buying an estimated $218 and bringing the position to 143 shares worth $1.14K. The position accounts for ﹤0.01% of the portfolio, ranked #7225.
Osaic Holdings first reported a position in LPCN in Q1 2020 and has held it in 25 quarters since. The position peaked at $25K in Q1 2021. 47 funds tracked by Wall St. Rank hold LPCN as of Q1 2026.
- Osaic Holdings held 143 shares of Lipocine worth $1.14K as of Q1 2026.
- Osaic Holdings bought 25 Lipocine shares in Q1 2026, an estimated $218.
- Lipocine made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #7225 holding.
- Osaic Holdings first reported a position in Lipocine in Q1 2020 and has held it in 25 quarters since.
- Osaic Holdings's Lipocine position peaked at $25K in Q1 2021.
- 47 funds tracked by Wall St. Rank held Lipocine as of Q1 2026.
Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.